Skip to main content

Delcath Systems, Inc.

DCTH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000872912

No open-market purchases or sales by Delcath Systems, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Delcath Systems, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Delcath Systems, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Delcath Systems, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Czerepak ElizabethDirector–May 14, 20261
Salamon Steven A JDirector3,413,468IndirectMay 14, 20261
Martell Bridget ADirector–May 14, 20261
Sylvester John RichardDirector14,936May 14, 20262
Aharon GilDirector3,413,468IndirectMay 14, 20261
Pennell SandraChief Financial Officer77,018Mar 6, 20262
Michel Gerard JCHIEF EXECUTIVE OFFICER342,034Mar 3, 20263
Vukovic VojoCHIEF MEDICAL OFFICER168,882Feb 18, 20261
Muir KevinGM INTERVENTIONAL ONCOLOGY18,582Feb 18, 20261
Hoffman David L.GEN'L COUNSEL, CCO & SECY74,330Feb 18, 20261
Rook Martha S.CHIEF OPERATING OFFICER–Feb 18, 20261
Rosalind Advisors, Inc.Director3,413,468IndirectMay 9, 20250
Stoll Roger G PhDDirector–May 28, 20240
Dias AnthonyVP FINANCE–Feb 20, 20240
Purpura JohnCHIEF OPERATING OFFICER41,526Jan 26, 20240
John JohnnySVP CLINICAL DEV & MED AFFAIRS–Jan 26, 20240
Padula ChristineSee Remarks–Oct 19, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 6, 2026 (view filing)Mar 6Same dayPennell SandraChief Financial OfficerPPurchase+5.53K$9.04+$50.0K+7.7%77.0K after
Mar 3, 2026 (view filing)Mar 21 dayMichel Gerard JCHIEF EXECUTIVE OFFICERPPurchase+11.2K$8.96+$100.4K+3.4%342.0K after
Nov 25, 2025 (view filing)Nov 214 daysSylvester John RichardDirectorPPurchase+4.39K$8.89+$39.0K+41.6%14.9K after
Nov 13, 2025 (view filing)Nov 112 daysMichel Gerard JCHIEF EXECUTIVE OFFICERPPurchase+11.5K$8.53+$98.1K+3.6%330.8K after
Mar 20, 2024 (view filing)7:07 PM ETMar 191 dayRosalind Advisors, Inc. and 2 othersDirectorPPurchaseDelcath Systems, Inc. Common Shares+619.9K$3.71+$2.30M–836.1K afterDerivative
Mar 20, 2024 (view filing)Mar 191 dayAharon GilDirectorPPurchase+26.9K$3.72+$100.0K+2.6%1.07M after
Mar 20, 2024 (view filing)Mar 191 daySalamon Steven A JDirectorPPurchase+26.9K$3.72+$100.0K+2.5%1.12M after
Dec 14, 2023 (view filing)Dec 122 daysVukovic VojoChief Medical OfficerPPurchase+40.0K$3.00+$120.0K+66.7%100.0K after
Dec 11, 2023 (view filing)Dec 83 daysMichel Gerard JChief Executive OfficerPPurchase+34.0K$2.94+$100.0K+14.9%262.3K after
Nov 21, 2023 (view filing)11:07 AM ETNov 174 daysRosalind Advisors, Inc. and 2 othersDirectorPPurchase+100.0K$2.40+$240.4K+10.7%1.04M after
Nov 21, 2023 (view filing)Nov 174 daysPennell SandraSVP of Finance, PFO and PAOPPurchase+30.0K$2.43+$72.9KNew position30.0K after
Nov 20, 2023 (view filing)Nov 164 daysVukovic VojoChief Medical OfficerPPurchase+60.0K$2.48+$148.8KNew position60.0K after
Nov 20, 2023 (view filing)Nov 164 daysHoffman David L.See RemarksPPurchase+40.0K$2.48+$99.2KNew position40.0K after
Oct 17, 2023 (view filing)Oct 134 daysPurpura JohnChief Operating OfficerPPurchase+14.5K$3.44+$49.9K+53.7%41.5K after
Aug 23, 2023 (view filing)Aug 212 daysSylvester John RichardDirectorPPurchase+10.6K$4.80+$50.6KNew position10.6K after
Mar 30, 2023 (view filing)9:00 AM ETMar 291 dayMichel Gerard JChief Executive OfficerPPurchase+19.6K$4.84+$95.1K+11.1%197.2K after
Mar 30, 2023 (view filing)9:00 AM ETMar 291 dayMichel Gerard JChief Executive OfficerPPurchase+47.8K$0.125+$5.97K–16.7K afterDerivative2 lots
Dec 16, 2022 (view filing)Dec 142 daysRosalind Advisors, Inc.DirectorPPurchase+15.2K$3.62+$55.1K+3.4%459.3K after
Dec 16, 2022 (view filing)Dec 142 daysSalamon Steven A JDirectorPPurchase+15.2K$3.62+$55.1K+3.5%455.3K after
Dec 14, 2022 (view filing)Dec 131 dayAharon GilDirectorPPurchaseDELCATH SYSTEMS, INC. COMMON+692.0K$2.89+$2.00M–1.26M afterDerivativeDuplicate filing
Dec 14, 2022 (view filing)Dec 131 dayRosalind Advisors, Inc.DirectorPPurchaseDELCATH SYSTEMS, INC. COMMON+692.0K$2.89+$2.00M–1.26M afterDerivativeDuplicate filing
Dec 14, 2022 (view filing)Dec 131 daySalamon Steven A JDirectorPPurchaseDELCATH SYSTEMS, INC. COMMON+692.0K$2.89+$2.00M–1.26M afterDerivative
Dec 14, 2022 (view filing)Dec 131 dayMichel Gerard JChief Executive OfficerPPurchase+51.7K$2.90+$150.0K+41.1%177.6K after
Jul 21, 2022 (view filing)Jul 201 dayMichel Gerard JChief Executive OfficerPPurchase+62.8K$3.98+$250.0K+99.6%125.9K after
Jul 20, 2022 (view filing)Jul 182 daysAharon GilDirectorPPurchaseDELCATH SYSTEMS, INC. COMMON+566.8K$3.97+$2.25M–566.8K afterDerivativeDuplicate filing
Jul 20, 2022 (view filing)Jul 182 daysSalamon Steven A JDirectorPPurchaseDELCATH SYSTEMS, INC. COMMON+566.8K$3.97+$2.25M–566.8K afterDerivative
May 18, 2022 (view filing)May 162 daysPurpura JohnChief Operating OfficerPPurchase+3.30K$4.61+$15.2K+13.9%27.0K after
May 16, 2022 (view filing)May 133 daysSalamon Steven A JDirectorPPurchase+5.00K$5.03+$25.1K+1.1%440.1K after
May 13, 2022 (view filing)May 121 daySalamon Steven A JDirectorPPurchase+6.00K$4.90+$29.4K+25.6%29.4K after
Apr 21, 2022 (view filing)Apr 192 daysRosalind Advisors, Inc.DirectorPPurchase+1.60K$6.25+$10.0K+0.4%433.1K after
Apr 20, 2022 (view filing)Apr 191 daySalamon Steven A JDirectorPPurchase+1.60K$6.25+$10.0K+0.4%429.1K after
Apr 19, 2022 (view filing)Apr 181 dayRosalind Advisors, Inc.DirectorPPurchase+2.00K$6.35+$12.7K+0.5%431.5K after
Apr 19, 2022 (view filing)Apr 181 dayAharon GilDirectorPPurchase+2.00K$6.35+$12.7K+0.5%404.0K after
Apr 18, 2022 (view filing)Apr 18Same dayMichel Gerard JSee RemarksPPurchase+2.00K$6.37+$12.7K+3.3%63.0K after2 lots
Apr 14, 2022 (view filing)Apr 131 dayRosalind Advisors, Inc.DirectorPPurchase+1.50K$6.45+$9.68K+0.4%429.5K after
Apr 14, 2022 (view filing)Apr 131 daySalamon Steven A JDirectorPPurchase+1.50K$6.45+$9.68K+0.4%427.5K after
Apr 12, 2022 (view filing)Apr 12Same dayRosalind Advisors, Inc.DirectorPPurchase+2.50K$6.48+$16.2K+0.6%428.0K after
Apr 12, 2022 (view filing)Apr 12Same daySalamon Steven A JDirectorPPurchase+2.50K$6.48+$16.2K+0.6%425.0K after
Apr 11, 2022 (view filing)Apr 11Same dayPurpura JohnChief Operating OfficerPPurchase+5.00K$6.59+$33.0K+26.7%23.7K after
Apr 8, 2022 (view filing)Apr 6-72 daysSalamon Steven A JDirectorPPurchase+2.00K$6.45+$12.9K+0.5%423.5K after2 lots
Apr 8, 2022 (view filing)Apr 6-72 daysRosalind Advisors, Inc.DirectorPPurchase+2.00K$6.45+$12.9K+0.5%425.5K after2 lots
Apr 8, 2022 (view filing)Apr 8Same dayMichel Gerard JSee RemarksPPurchase+2.00K$6.57+$13.1K+3.4%61.0K after2 lots
Apr 5, 2022 (view filing)Nov 19, 2020502 daysPurpura JohnChief Operating OfficerPPurchase+1.60K$12.68+$20.3K+12.2%14.7K afterAmended
Jan 3, 2022 (view filing)Dec 30, 20214 daysSalamon Steven A JDirectorPPurchase+2.00K$7.56+$15.1K+0.5%421.5K after
Jan 3, 2022 (view filing)Dec 30, 20214 daysRosalind Advisors, Inc.DirectorPPurchase+2.00K$7.56+$15.1K+0.5%423.5K after
Dec 6, 2021 (view filing)Dec 24 daysMichel Gerard JSee RemarksPPurchase+23.2K$8.61+$199.8K+64.7%59.0K after
Jul 1, 2021 (view filing)Jun 301 daySalamon Steven A JDirectorPPurchase+5.50K$12.76+$70.2K+1.3%419.5K after
Jul 1, 2021 (view filing)Jun 301 dayRosalind Advisors, Inc.DirectorPPurchase+5.50K$12.76+$70.2K+1.3%421.5K after
Jul 1, 2021 (view filing)Jun 283 daysRosalind Advisors, Inc.DirectorPPurchase+5.00K$11.56+$57.8K+1.2%416.0K afterAmended